Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02215096 · COMPLETED

Trial details

NCT number

NCT02215096

Sponsor

GlaxoSmithKline

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-11-13

Primary completion

2019-10-03

Enrollment

37

View on ClinicalTrials.gov